Literature DB >> 31559039

A retrospective study analyzing missed diagnosis of lung metastases at their early stages on computed tomography.

Huai Chen1, Suidan Huang1, Qingsi Zeng1, Min Zhang2, Zhiwen Ni1, Xiaoling Li1, Xiaoyin Xu2.   

Abstract

BACKGROUND: Lungs are one of the target organs of metastases of primary lung, breast, liver, colorectal, and esophageal cancer. While computed tomography (CT) is the most widely used modality for detecting lung metastases, it is still very challenging to detect them at the earlier stages. If lung metastases could be found on CT scans at the earliest time points, patients would benefit by beginning treatment earlier. The objective of this study was to demonstrate that CT can reveal lung metastases in many cases at even earlier stages than current radiological practice may find.
METHODS: One hundred patients with lung metastases were randomly selected and their surveillance CT scans were analyzed retrospectively. The patients had primary cancer in the breasts, lungs, esophagus, colorectum, and liver. All patients had multiple CT examinations of the lungs and their metastases, if any, were confirmed by subsequent CT scans. The earliest CT scans were examined to determine whether lung metastases at the same locations had been diagnosed or missed. Missed lung metastases, categorized by type of the primary cancer and adjacency to nearby blood vessels, were statistically analyzed.
RESULTS: There were 36/100 (36%) cases of missed lung metastases, including 15 cases of single metastasis and 21 cases of multiple metastases. There were a total of 174 missed loci of lung metastases. Where metastases were missed, there was a statistically significant difference (P<0.001) in their distribution within the sub-regions of the lungs. Adjacency to blood vessels appeared to be a significant factor in metastases being missed during diagnosis (P<0.001).
CONCLUSIONS: There was a considerable percentage of early lung metastases that were missed by radiologists but actually appeared on CT scans. The capability of CT to reveal such early metastases opens up an opportunity to move up the time points of detecting lung metastases through clinical and training improvement and technology development such as computer-aided detection.

Entities:  

Keywords:  Computed tomography (CT); early detection; lung metastases

Year:  2019        PMID: 31559039      PMCID: PMC6753459          DOI: 10.21037/jtd.2019.08.19

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  28 in total

1.  Computerized analysis of the likelihood of malignancy in solitary pulmonary nodules with use of artificial neural networks.

Authors:  K Nakamura; H Yoshida; R Engelmann; H MacMahon; S Katsuragawa; T Ishida; K Ashizawa; K Doi
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

Review 2.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

3.  Evaluation of effectiveness of a computer system (CAD) in the identification of lung nodules with low-dose MSCT: scanning technique and preliminary results.

Authors:  F Fraioli; C Catalano; M Almberger; L Bertoletti; V Cantisani; M Danti; F Pediconi; R Passariello
Journal:  Radiol Med       Date:  2005 Jan-Feb       Impact factor: 3.469

4.  Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT.

Authors:  Tobias Schroeder; Stefan G Ruehm; Jörg F Debatin; Mark E Ladd; Jörg Barkhausen; Susanne C Goehde
Journal:  AJR Am J Roentgenol       Date:  2005-10       Impact factor: 3.959

5.  Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.

Authors:  Jared A Christensen; Mark A Nathan; Brian P Mullan; Thomas E Hartman; Stephen J Swensen; Val J Lowe
Journal:  AJR Am J Roentgenol       Date:  2006-11       Impact factor: 3.959

Review 6.  Atypical pulmonary metastases: spectrum of radiologic findings.

Authors:  J B Seo; J G Im; J M Goo; M J Chung; M Y Kim
Journal:  Radiographics       Date:  2001 Mar-Apr       Impact factor: 5.333

7.  Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases.

Authors:  J M Goo; J G Im; K H Do; J S Yeo; J B Seo; H Y Kim; J K Chung
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

8.  Screening for lung cancer with low-dose spiral computed tomography.

Authors:  Stephen J Swensen; James R Jett; Jeff A Sloan; David E Midthun; Thomas E Hartman; Anne-Marie Sykes; Gregory L Aughenbaugh; Frank E Zink; Shauna L Hillman; Gayle R Noetzel; Randolph S Marks; Amy C Clayton; Peter C Pairolero
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

9.  F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.

Authors:  S M Bakheet; M Saleem; J Powe; A Al-Amro; S G Larsson; Z Mahassin
Journal:  Clin Nucl Med       Date:  2000-04       Impact factor: 7.794

10.  The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.

Authors:  Gerarda J Herder; Richard P Golding; Otto S Hoekstra; Emile F Comans; Gerrit J Teule; Pieter E Postmus; Egbert F Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-03       Impact factor: 9.236

View more
  3 in total

1.  Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.

Authors:  Wei Zhang; Lichen Ji; Xugang Zhong; Senbo Zhu; Yi Zhang; Meng Ge; Yao Kang; Qing Bi
Journal:  Front Public Health       Date:  2022-05-31

2.  Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study.

Authors:  Jida Guo; Shengqiang Zhang; Huawei Li; Mohamed Osman Omar Hassan; Tong Lu; Jiaying Zhao; Linyou Zhang
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 3.  Possible Bias in Supervised Deep Learning Algorithms for CT Lung Nodule Detection and Classification.

Authors:  Nikos Sourlos; Jingxuan Wang; Yeshaswini Nagaraj; Peter van Ooijen; Rozemarijn Vliegenthart
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.